Global Anti-Suicide Drugs Market Research Report 2019
Table of Contents
Executive Summary
1 Anti-Suicide Drugs Market Overview
- 1.1 Product Overview and Scope of Anti-Suicide Drugs
- 1.2 Anti-Suicide Drugs Segment by Type
- 1.2.1 Global Anti-Suicide Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Anti-Depressants and Anti-Anxiety Drugs
- 1.2.3 Anti-Psychotic Drugs
- 1.2.4 NMDA Antagonist
- 1.2.5 Antibiotic Analog
- 1.3 Anti-Suicide Drugs Segment by Application
- 1.3.1 Anti-Suicide Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Retail pharmacies
- 1.3.4 Online pharmacies
- 1.4 Global Anti-Suicide Drugs Market by Region
- 1.4.1 Global Anti-Suicide Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Anti-Suicide Drugs Market Size
- 1.5.1 Global Anti-Suicide Drugs Revenue (2014-2025)
- 1.5.2 Global Anti-Suicide Drugs Production (2014-2025)
2 Global Anti-Suicide Drugs Market Competition by Manufacturers
- 2.1 Global Anti-Suicide Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Anti-Suicide Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Anti-Suicide Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Anti-Suicide Drugs Production Sites, Area Served, Product Types
- 2.5 Anti-Suicide Drugs Market Competitive Situation and Trends
- 2.5.1 Anti-Suicide Drugs Market Concentration Rate
- 2.5.2 Anti-Suicide Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Anti-Suicide Drugs Production Market Share by Regions
- 3.1 Global Anti-Suicide Drugs Production Market Share by Regions
- 3.2 Global Anti-Suicide Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Anti-Suicide Drugs Production
- 3.4.1 North America Anti-Suicide Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Anti-Suicide Drugs Production
- 3.5.1 Europe Anti-Suicide Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Anti-Suicide Drugs Production (2014-2019)
- 3.6.1 China Anti-Suicide Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Anti-Suicide Drugs Production (2014-2019)
- 3.7.1 Japan Anti-Suicide Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Anti-Suicide Drugs Consumption by Regions
- 4.1 Global Anti-Suicide Drugs Consumption by Regions
- 4.2 North America Anti-Suicide Drugs Consumption (2014-2019)
- 4.3 Europe Anti-Suicide Drugs Consumption (2014-2019)
- 4.4 China Anti-Suicide Drugs Consumption (2014-2019)
- 4.5 Japan Anti-Suicide Drugs Consumption (2014-2019)
5 Global Anti-Suicide Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Anti-Suicide Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Anti-Suicide Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Anti-Suicide Drugs Price by Type (2014-2019)
- 5.4 Global Anti-Suicide Drugs Production Growth by Type (2014-2019)
6 Global Anti-Suicide Drugs Market Analysis by Applications
- 6.1 Global Anti-Suicide Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Anti-Suicide Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Anti-Suicide Drugs Business
- 7.1 Pfizer
- 7.1.1 Pfizer Anti-Suicide Drugs Production Sites and Area Served
- 7.1.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.1.3 Pfizer Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 AstraZeneca plc
- 7.2.1 AstraZeneca plc Anti-Suicide Drugs Production Sites and Area Served
- 7.2.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.2.3 AstraZeneca plc Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Eli Lilly and Company
- 7.3.1 Eli Lilly and Company Anti-Suicide Drugs Production Sites and Area Served
- 7.3.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.3.3 Eli Lilly and Company Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Allergan plc
- 7.4.1 Allergan plc Anti-Suicide Drugs Production Sites and Area Served
- 7.4.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.4.3 Allergan plc Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 GlaxoSmithKline plc
- 7.5.1 GlaxoSmithKline plc Anti-Suicide Drugs Production Sites and Area Served
- 7.5.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.5.3 GlaxoSmithKline plc Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Merck & Co., Inc
- 7.6.1 Merck & Co., Inc Anti-Suicide Drugs Production Sites and Area Served
- 7.6.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.6.3 Merck & Co., Inc Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 H. Lundbeck A/S
- 7.7.1 H. Lundbeck A/S Anti-Suicide Drugs Production Sites and Area Served
- 7.7.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.7.3 H. Lundbeck A/S Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 NeuroRx, Inc
- 7.8.1 NeuroRx, Inc Anti-Suicide Drugs Production Sites and Area Served
- 7.8.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.8.3 NeuroRx, Inc Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Johnson & Johnson
- 7.9.1 Johnson & Johnson Anti-Suicide Drugs Production Sites and Area Served
- 7.9.2 Anti-Suicide Drugs Product Introduction, Application and Specification
- 7.9.3 Johnson & Johnson Anti-Suicide Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
8 Anti-Suicide Drugs Manufacturing Cost Analysis
- 8.1 Anti-Suicide Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Anti-Suicide Drugs
- 8.4 Anti-Suicide Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Anti-Suicide Drugs Distributors List
- 9.3 Anti-Suicide Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Anti-Suicide Drugs Market Forecast
- 11.1 Global Anti-Suicide Drugs Production, Revenue Forecast
- 11.1.1 Global Anti-Suicide Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Anti-Suicide Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Anti-Suicide Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Anti-Suicide Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Anti-Suicide Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Anti-Suicide Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Anti-Suicide Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Anti-Suicide Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Anti-Suicide Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Anti-Suicide Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Anti-Suicide Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Anti-Suicide Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Anti-Suicide Drugs Consumption Forecast (2019-2025)
- 11.4 Global Anti-Suicide Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Anti-Suicide Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.
The global Anti-Suicide Drugs market is valued at 3600 million US$ in 2018 is expected to reach 5210 million US$ by the end of 2025, growing at a CAGR of 4.7% during 2019-2025.
This report focuses on Anti-Suicide Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Suicide Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer
AstraZeneca plc
Eli Lilly and Company
Allergan plc
GlaxoSmithKline plc
Merck & Co., Inc
H. Lundbeck A/S
NeuroRx, Inc
Johnson & Johnson
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Anti-Depressants and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Segment by Application
Hospitals
Retail pharmacies
Online pharmacies